Slate Medicines | $130,000,000 | (Feb 25, 2026)
Letter AI | $40,000,000 | (Feb 25, 2026)
Subject | $28,000,000 | (Feb 25, 2026)
Certified by Founder
Lodge
Squint
start up
United States
- San Francisco, CA
- 13/08/2025
- Series B
- $40,000,000
Squint is a Manufacturing Intelligence Platform that the world's leading manufacturers use to capture expert knowledge, unlock operator performance, and analyze production insights. Operators love Squint because it uniquely combines spatial computing, LLMs, and human expertise into a magical experience.
Our story starts with manufacturing, a $7T industry that is the foundation of the world as we know it. Faced with a generational inflection point, the industry is in need of a new wave of technology that bridges the knowledge gap between the retiring and incoming workforce.
Squint’s mission is to accelerate human potential by bringing digital knowledge into the real world.
- Industry Software Development
- Website https://www.squint.ai/
- LinkedIn https://www.linkedin.com/company/squintai/
Centauri Therapeutics Limited | $8,107,170 | (Feb 25, 2026)
Slang AI | $36,000,000 | (Feb 25, 2026)
Brilliant Harvest Inc. | $4,000,000 | (Feb 25, 2026)
Koah | $20,500,000 | (Feb 25, 2026)
Nimble | $47,000,000 | (Feb 25, 2026)
General Magic | $7,200,000 | (Feb 25, 2026)
Circadian Risk Inc. | $6,000,000 | (Feb 25, 2026)
Neural Earth | $9,300,000 | (Feb 25, 2026)
Jampack AI | $3,200,000 | (Feb 25, 2026)